The annual conference will feature an interdisciplinary cast of researchers, industry leaders and policymakers who will discuss advances in therapeutics, including COVID-19 treatments.
April 9, 2021
Registration is open for the 2021 Stanford Drug Discovery Symposium, which will take place virtually April 19-20.
The conference, which is free and open to the public, will feature dozens of academic researchers, industry leaders, investors, policymakers and others discussing a broad range of topics related to drug research and development.
Highlights will include a panel discussion on changes in the drug industry brought about by the outbreak of COVID-19 and talks on new manufacturing techniques.
Speakers this year include Stanford’s Brian Kobilka, MD, the Hélène Irwin Fagan Chair in Cardiology and winner of the 2012 Nobel Prize in chemistry; Stanford’s Roger Kornberg, PhD, the Mrs. George A. Winzer Professor in Medicine and winner of the 2006 Nobel Prize in Chemistry; and Janet Woodcock, MD, acting commissioner of the Food and Drug Administration.
Lifetime achievement awards will be presented to Douglas Lowy, MD, principal deputy director of the National Cancer Institute, and John Schiller, PhD, deputy chief of the cellular oncology laboratory at the National Cancer Institute for their work on the human papilloma virus vaccine.
The Stanford Cardiovascular Insitute is organizing the event. Conference registration is available online.
About Stanford Medicine
Stanford Medicine is an integrated academic health system comprising the Stanford School of Medicine and adult and pediatric health care delivery systems. Together, they harness the full potential of biomedicine through collaborative research, education and clinical care for patients. For more information, please visit med.stanford.edu.
